Current pharmacotherapy options for bulimia nervosa and binge eating disorder
✍ Scribed by McElroy, Susan L; Guerdjikova, Anna I; Mori, Nicole; O’Melia, Anne M
- Book ID
- 120276167
- Publisher
- Informa plc
- Year
- 2012
- Tongue
- English
- Weight
- 336 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1465-6566
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Objective: Potential differences in the hedonics of binge eating between female subjects with bulimia nervosa (bn) and female subjects with binge eating disorder (bed) were examined. ## Method: Women seeking treatment for bn (n = 29) and bed (n = 49) completed the eating hedonics questionnaire
## Objective: To compare the pathway to binge eating and clinical characteristics of binge eating disorder patients (bed) and nonpurging bulimics. ## Methods: The subjects were 45 nonpurging bulimics and 45 bed patients who consecutively sought treatment in an outpatient eating disorders unit. th
## Abstract ## **Objective:** In DSM‐IV, to be diagnosed with Bulimia Nervosa (BN) or the provisional diagnosis of Binge Eating Disorder (BED), an individual must experience episodes of binge eating is “at least twice a week” on average, for 3 or 6 months, respectively. The purpose of this review